BURSHTEIN GREGORY (Chief of R&D) received a stock award from ENTERA BIO LTD.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 7/18/2025ACC: 0001178913-25-002412
Officer· Chief of R&D
Since May 2024
+226.32K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
226.32K acquired
Non-Derivative Transactions1
Ordinary Shares, par value NIS 0.0000769 per share
Direct
Shares
+26.32K
Price / share
—
Trade value
—
% of position
35.0%
7/16/2025
75.13K→101.44K
Total
Net shares
+26.32K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, par value NIS 0.0000769 per share Direct | 7/16/2025 | A · Award | +26.32K | — | — | 35.0% | 75.13K | 101.44K |
| Total | +26.32K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Ordinary Shares, par value NIS 0.0000769 per share
200K shares
Shares
+200K
Strike price
2.28
Held after
200K
Exercisable
—
7/16/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Ordinary Shares, par value NIS 0.0000769 per share200K shares | 7/16/2025 | A · Award | +200K | 2.28 | — | 200K |